Abstract:O-GlcNAc transferase (OGT) is overexpressed in aggressive prostate cancer. OGT modifies intra-cellular proteins via single sugar conjugation (O-GlcNAcylation) to alter their activity. We recently discovered the first fast-acting OGT inhibitor OSMI-2. Here, we probe the stability and function of the chromatin O-GlcNAc and identify transcription factors that coordinate with OGT to promote proliferation of prostate cancer cells. Methods: Chromatin immunoprecipitation (ChIP) coupled to sequencing (seq), formaldehyde-assisted isolation of regulatory elements, RNA-seq and reverse-phase protein arrays (RPPA) were used to study the importance of OGT for chromatin structure and transcription. Mass spectrometry, western blot, RT-qPCR, cell cycle analysis and viability assays were used to establish the role of OGT for MYC-related processes. Prostate cancer patient data profiled for both mRNA and protein levels were used to validate findings. Results: We show for the first time that OGT inhibition leads to a rapid loss of O-GlcNAc chromatin mark. O-GlcNAc ChIP-seq regions overlap with super-enhancers (SE) and MYC binding sites. OGT inhibition leads to down-regulation of SE-dependent genes. We establish the first O-GlcNAc chromatin consensus motif, which we use as a bait for mass spectrometry. By combining the proteomic data from oligonucleotide enrichment with O-GlcNAc and MYC ChIP-mass spectrometry, we identify host cell factor 1 (HCF-1) as an interaction partner of MYC. Inhibition of OGT disrupts this interaction and compromises MYC's ability to confer androgen-independent proliferation to prostate cancer cells. We show that OGT is required for MYC-mediated stabilization of mitotic proteins, including Cyclin B1, and/or the increased translation of their coding transcripts. This implies that increased expression of mRNA is not always required to achieve increased protein expression and confer aggressive phenotype. Indeed, high expression of Cyclin B1 protein has strong predictive value in prostate cancer patients (p=0.000014) while mRNA does not. Conclusions: OGT promotes SE-dependent gene expression. OGT activity is required for the interaction between MYC and HCF-1 and expression of MYC-regulated mitotic proteins. These features render OGT essential for the androgen-independent, MYC-driven proliferation of prostate cancer cells. Androgen-independency is the major mechanism of prostate cancer progression, and our study identifies OGT as an essential mediator in this process.

Suppressed OGT Expression Inhibits Cell Proliferation While Inducing Cell Apoptosis in Bladder Cancer

Suppressed OGT Expression Inhibits Cell Proliferation and Modulates EGFR Expression in Renal Cell Carcinoma

O-GlcNAcylation Promotes Malignant Phenotypes of Bladder Cancer Cells

Silencing Β-Linked N-acetylglucosamine Transferase Induces Apoptosis in Human Gastric Cancer Cells Through PUMA and Caspase-3 Pathways.

Ott_a_258175 445..454

O-GlcNAcylation Enhances NUSAP1 Stability and Promotes Bladder Cancer Aggressiveness

Suppression of OGT by Microrna24 Reduces FOXA1 Stability and Prevents Breast Cancer Cells Invasion.

Proteomic Analysis of the OGT Interactome: Novel Links to Epithelial-Mesenchymal Transition and Metastasis of Cervical Cancer

O-linked N-acetylglucosamine Transferase (OGT) is Overexpressed and Promotes O-linked Protein Glycosylation in Esophageal Squamous Cell Carcinoma

Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder

O-GlcNAcylation determines the function of the key O-GalNAc glycosyltransferase C1GalT1 in bladder cancer

Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling

The roles of OGT and its mechanisms in cancer

High OGT activity is essential for MYC-driven proliferation of prostate cancer cells

O‐GlcNAc transferase activates stem‐like cell potential in hepatocarcinoma through O‐GlcNAcylation of eukaryotic initiation factor 4E

Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263

Ogt Demonstrated Conspicuous Clinical Significance in Cancers, from Pan-Cancer to Small-Cell Lung Cancer

O-GlcNAcylation in cancer development and immunotherapy

Regulation and Clinical Significance of O-GlcNAc Transferase in Cancer

Inhibition of GLS Suppresses Proliferation and Promotes Apoptosis in Prostate Cancer

Downregulation of Angiogenin Inhibits the Growth and Induces Apoptosis in Human Bladder Cancer Cells Through Regulating AKT/mTOR Signaling Pathway.